FOOT: Fifth Metatarsal Orthopedic Outcome Trial

Sponsor
Isala (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05450107
Collaborator
(none)
64
2
24

Study Details

Study Description

Brief Summary

Fractures of the shaft, distal to zone three, of the fifth metatarsal often occur after foot distortion. There is very little evidence available regarding the optimal treatment. Currently the most common treatment is prolonged cast immobilization. Operative treatment has been reported as an alternative and could promote early recovery. No comparative study has been published regarding optimal treatment

Condition or Disease Intervention/Treatment Phase
  • Procedure: Open Reduction Internal Fixation
  • Procedure: Cast immobilisation
N/A

Detailed Description

Objective: The main objective is to determine experienced pain, as measured by NRS-11 score, 3 months after intervention and compare this between the intervention and control group. Secondary objectives are functional outcome as measured by AOFAS Lesser Toe Scale, FAAM score, progress of NRS-11 score through time and PROMIS Mobility/pain interference. Furthermore, quality and duration of fracture healing will be compared between groups. The impact on daily life will be compared as measured by duration of return to work and normal footwear.

Study design: Randomised controlled clinical intervention trial

Study population: Humans with an acute shaft fracture of the fifth metatarsal bone, 18 years or older.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
64 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled clinical intervention trialRandomized controlled clinical intervention trial
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Treatment of Fifth Metatarsal Shaft Fractures: A Randomized Controlled Trial
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

The intervention group is offered surgical treatment of the shaft fracture of the fifth metatarsal bone with ORIF. Depending on the type of shaft fracture this will be either lag screw fixation or plate fixation. After surgery a period of cast immobilisation with gradual increase of weight bearing will commence

Procedure: Open Reduction Internal Fixation
Surgical intervention by lag screw or plate fixation

Active Comparator: Control

The control group (conservative treatment), will receive a period of cast immobilisation, with a gradual increase in weight bearing by protocol.

Procedure: Cast immobilisation
Cast immobilsation for a total of 6 weeks with gradual increase in weight bearing after 2 weeks

Outcome Measures

Primary Outcome Measures

  1. Numerical rating scale-11 score for pain 3 months [3 months after intervention]

    Numerical rating scale, score ranging from 0-10 where 10 is a worse outcome

Secondary Outcome Measures

  1. Numerical rating scale-11 score for pain through time [0-12 months after intervention]

    Numerical Rating Scale-11 score progression through different time points (6 weeks, 3,6 and 12 months after intervention. Score ranging from 0-10. A Higher score is a worse outcome

  2. American Orthopedic Foot &Ankle Society Lesser Toe Scale [3 months after intervention]

    American Orthopedic Foot &Ankle Society Lesser Toe Scale between groups, functional outcome measure for patients with lesser toe (i.e. excluding hallux) and midfoot pathology. Score ranging from 0-100. A Higher score is a better outcome

  3. Foot and Ankle Ability Measure [6 weeks, 3,6 and 12 months after intervention]

    Foot and Ankle Ability Measure, a score with two subscales: Activities of Daily Living (ADL) and sports. The questions concern function of the foot and ankle. progression through different time points (6 weeks, 3,6 and 12 months after intervention). Score ranging from 0-120. A higher score is a better outcome

  4. Patient Reported Outcome Measure Information System - Mobility [6 weeks, 3,6 and 12 months after intervention]

    patient reported outcome measures by using Computer Adaptive Testing. Results in a normalized score ranging from 0-100 where an average human being will score 50. Higher score is a better outcome.

  5. Patient Reported Outcome Measure Information System - Pain Interference [6 weeks, 3,6 and 12 months after intervention]

    Patient reported outcome measures by using Computer Adaptive Testing. Results in a normalized score ranging from 0-100 where an average human being will score 50. Higher score is a better outcome.

  6. Return to work [0-12 months]

    Duration of resumption of work

  7. Return to normal footwear [0-12 months]

    Duration of return to normal footwear

  8. Malunion [6 weeks after intervention]

    Length of fractured fifth metatarsal as compared to ipsilateral fifth metatarsal

  9. Non union [0-6 months]

    Determined by plain X-ray on 6 weeks, 3 months and 6 months, categorical outcome

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years or older at the time of study entry

  • Informed consent

  • Competent to participate in follow up and fill out questionnaires

  • Dislocated (1mm or more on plain radiography) fracture of the shaft, distal from zone 3, of the fifth metatarsal according to the Orthopedic Trauma Association (OTA) classification 87.5.3 A-C

Exclusion Criteria:
  • Open fracture

  • Proximal fifth metatarsal fracture, Jones fracture

  • Clinically significant or symptomatic vascular or neurologic pathology on the ipsilateral leg

  • Former surgery or history of development disorder of the contralateral fifth metatarsal

  • Multiple fractured metatarsals in the affected foot

  • Medical history of Rheumatoid Arthritis

  • Unable to undergo surgical procedure

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Isala

Investigators

  • Principal Investigator: Rutger Zuurmond, MD, PhD, Isala

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Maarten Cornelissen, Coordinating Investigator, Isala
ClinicalTrials.gov Identifier:
NCT05450107
Other Study ID Numbers:
  • 80748.075.22
First Posted:
Jul 8, 2022
Last Update Posted:
Jul 12, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 12, 2022